291-Prognostic ctDNA Monitoring in Resectable NSCLC

This article details a study focused on using longitudinal ultrasensitive circulating tumor DNA (ctDNA) monitoring to improve risk prediction and management for patients with non-small cell lung cancer (NSCLC). The research, based on the TRACERx study cohort, leverages a highly sensitive, tumor-informed ctDNA assay to detect molecular residual disease (MRD) both before and after surgery. Findings ...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动